1 minute read
Pfizer and BioNTech have asked the Food and Drug Administration (FDA) to authorize their COVID-19 vaccine for children ages 5-11. The Pfizer-BioNTech vaccine is the only one currently approved by the FDA. It’s approved under emergency use authorization (EUA) rules for children ages 12-15.
The companies are asking to expand the EAU so that children ages 5-11 can receive the vaccine as well. A ruling is expected in a month or so and children ages 5-11 may be able to get vaccinated as soon as December.
Such authorization could speed up efforts from school systems that are looking to vaccinate their students, like the state of California.
Download the bulletin for more details.
This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.
National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.
